Adenovirus 36 E4 orf 1 gene and protein and their uses
US8008436B2 · kind B2 · utility
Assignees
Inventors
Key dates
| Filing date | Nov 30, 2006 |
| Grant date | Aug 30, 2011 |
| Priority date | — |
| Expiry date | Dec 9, 2026 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC12N2710/10332
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Expression of the E4 orf 1 gene of Ad-36 alone has been discovered to be responsible for the increased insulin sensitivity observed in Ad-36 infected animals, including increased adipogenesis. Ad-36 E4 orf 1 protein can be used to increase insulin sensitivity and ameliorate diabetes. Additionally, drugs that mimic the action of Ad-36 E4 orf 1 protein could be found. Ad-36 E4 orf 1 could also be used to increase fat cells in lipodystrophy. We have also discovered that Ad-36 infection in human skeletal muscle cells increased differentiation and insulin independent glucose uptake. It is expected that infection with Ad-36 E4 orf 1 gene will also cause these effects.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.